K820567 is an FDA 510(k) clearance for the TREP CARD EIKEN. Classified as Antigens, Nontreponemal, All (product code GMQ), Class II - Special Controls.
Submitted by Syn-Kit, Inc. (Mchenry, US). The FDA issued a Cleared decision on April 14, 1982 after a review of 43 days - a notably fast clearance cycle.
This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3820 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Syn-Kit, Inc. devices